The incidence of retinopathy of prematurity (ROP) , a blinding disease, is increasing; there is no way to prevent the disease at this time. ROP is highly correlated with prematurity as well as 02 toxicity and the less differentiated front of the developing vasculature is affected in ROP, not the mature vessels. However, there has been little work on the role of retinal endothelial cells (RCE) in the disease process. This proposal addresses both the questions of pathogenesis and potential therapies. We will use an in vitro model of RCE differentiation to examine superoxide dismutase (SOD) as a partial reflection of the ability of RCE at different points in differentiation to help detoxify some free radical products of 02 metabolism; SOD may be an important enzyme in this detoxification and also in differentiation. In this model we will also examine the effect on SOD of agents which may alter differentiation. Although the in vitro model allows us to test the hypothesis that the degree of differentiation determines the levels of SOD in EC, we need the full complexity of in vivo conditions to further explore the pathogenesis of ROP and evaluate potential intervention. We have developed a mouse model of quantifiable oxygen-induced vasculopathy and will use this model to study SOD enzyme activity and basic fibroblastic growth factor (bFGF) localization by immunohistochemistry in whole retinas and also examine SOD and bFGF mRNA expression (by in situ hybridization). We will compare the findings in our ROP model to those found in normally developing murine retina. Furthermore, we will compare the effect of agents known to inhibit angiogenesis: (1) alpha-interferon, an agent known to inhibit proliferation of EC in culture and currently in clinical trials for treatment of vascular tumors and (2) AGM-1470, a very promising angiostatic agent now in clinical trials as an anti-tumor agent. We will also examine agents which may increase SOD activity: SOD analogues and retinol (see Preliminary Results). Because of the direct clinical relevance we will also examine the effect of light and darkness on the development of neovascularization in the ROP model. There is both clinical evidence and evidence from in vitro experimentation in tissue culture that light levels may have an effect on ROP(Glass, et al, 1985; Dorey, et al, 1990).

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY008670-01A2
Application #
3265991
Study Section
Visual Sciences C Study Section (VISC)
Project Start
1992-09-30
Project End
1997-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Wallace, David K; Kraker, Raymond T; Freedman, Sharon F et al. (2017) Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. JAMA Ophthalmol 135:654-656
Joyal, Jean-Sébastien; Sun, Ye; Gantner, Marin L et al. (2016) Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. Nat Med 22:439-45
Chen, Jing; Stahl, Andreas; Hellstrom, Ann et al. (2011) Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr 23:173-8
Chen, Jing; Stahl, Andreas; Krah, Nathan M et al. (2011) Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation 124:1871-81
Stahl, Andreas; Connor, Kip M; Sapieha, Przemyslaw et al. (2010) The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 51:2813-26
Mantagos, Iason S; Vanderveen, Deborah K; Smith, Lois E H (2009) Emerging treatments for retinopathy of prematurity. Semin Ophthalmol 24:82-6
Lofqvist, Chatarina; Willett, Keirnan L; Aspegren, Oskar et al. (2009) Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci 50:1831-7
Löfqvist, Chatarina; Niklasson, Aimon; Engström, Eva et al. (2009) A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants. Pediatr Res 65:574-9
Chen, Jing; Connor, Kip M; Aderman, Christopher M et al. (2009) Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci 50:1329-35
Stahl, A; Connor, K M; Sapieha, P et al. (2009) Computer-aided quantification of retinal neovascularization. Angiogenesis 12:297-301

Showing the most recent 10 out of 28 publications